BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 21, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Antizol fomepizole small molecule inhibitor of alcohol dehydrogenase regulatory update

The FDA accepted for filing ORPH's sNDA for Antizol injection to treat methanol poisoning, and has granted the application priority...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >